Other OTC redness relievers
(α1 or α1/α2-AR agonist)
Commonly associated with
rebound redness and tachyphylaxis
Acts on the arteriole,
decreasing blood and oxygen
flow to surrounding tissue.
LUMIFY with low dose Brimonidine
(Selective α2-AR agonist)
No tachyphylaxis and virtually
no rebound redness in clinical trials
LUMIFY selectively constricts the
venule, while maintaining availability
of oxygen to surrounding tissue.